Knowledge Ecology International
Attending and mending the knowledge ecosystem
Revenues»Knowledge Ecology International
Menu Close
  • About
  • Areas of work
  • Coronavirus
  • Listserves
  • Videos
  • Publications
  • Databases
  • Donate

Revenues

AbbVie’s biologic Humira has earned more than $103 billion since entering the market in 2003

Posted on October 11, 2017 by Claire Cassedy

The biologic drug, Humira (adalimumab) is currently the best selling drug in the world, with revenues of more than $16 billion in 2016, and $4.7 billion in the 2nd quarter of 2017 ($52 million per day). HumiraRevenueTable.png
Continue Reading →

Access to Medicine AbbVie, Revenues

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

Categories

  • [Test] Post
  • About
  • Access to Knowledge
  • Access to Medicine
  • Competition
  • Delinkage
  • Economics
  • Events
  • Evidence
  • Government Funded research
  • influence
  • Intellectual Property Rights
  • Legislation
  • Litigation
  • Lobbying
  • Marketing
  • Meetings
  • Negotiations
  • Nuclear Proliferation
  • Orphan Drugs
  • Presentations
  • Privacy
  • Public Goods
  • Timelines
  • Trade
  • Transparency
  • WHO
  • WIPO
  • WTO
Knowledge Ecology International»Revenues
© 2021 Knowledge Ecology International. All rights reserved.
Hiero by aThemes